You are here

Sheila McLoughlin

Senior Group Leader: Discovery Bioscience

An enzymologist by training, Sheila is responsible for all screening and compound profiling activities. Prior to joining CRUK-TDL (then CRT-DL) in 2008, Sheila spent 20 years in drug discovery in agrochemical, biotech and biopharma companies most recently at UCB. She has developed expertise in several therapeutic areas including cancer, inflammation and cardiovascular and across multiple drug target classes. In addition to her track record in delivering small molecule screening and profiling data, Sheila has expertise in compound management and assay development. Sheila obtained her first degree in Biochemistry from the University of Bath and her PhD in biotechnology from the University of Cambridge.